Encision Inc. (ECIA)
OTCMKTS: ECIA · Delayed Price · USD
0.500
0.00 (-0.02%)
May 23, 2024, 3:58 PM EDT - Market closed

Encision Revenue

Encision had revenue of $6.87M in the twelve months ending December 31, 2023, down -3.92% year-over-year. Revenue in the quarter ending December 31, 2023 was $1.58M, a -6.08% decrease year-over-year. In the fiscal year ending March 31, 2023, Encision had annual revenue of $7.35M, a decrease of -4.16%.

Revenue (ttm)
$6.87M
Revenue Growth
-3.92%
P/S Ratio
0.86
Revenue / Employee
$221,502
Employees
31
Market Cap
5.88M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20237.35M-319.00K-4.16%
Mar 31, 20227.67M130.00K1.72%
Mar 31, 20217.54M-132.00K-1.72%
Mar 31, 20207.67M-1.13M-12.87%
Mar 31, 20198.80M48.46K0.55%
Mar 31, 20188.75M-116.00K-1.31%
Mar 31, 20178.87M-466.00K-4.99%
Mar 31, 20169.34M-335.00K-3.46%
Mar 31, 20159.67M-875.64K-8.30%
Mar 31, 201410.55M-1.22M-10.37%
Mar 31, 201311.77M-1.22M-9.41%
Mar 31, 201212.99M1.37M11.81%
Mar 31, 201111.62M-1.22M-9.50%
Mar 31, 201012.84M46.71K0.37%
Mar 31, 200912.79M723.63K6.00%
Mar 31, 200812.07M1.06M9.59%
Mar 31, 200711.01M1.88M20.63%
Mar 31, 20069.13M1.07M13.33%
Mar 31, 20058.05M767.76K10.54%
Mar 31, 20047.29M473.66K6.95%
Mar 31, 20036.81M1.95M40.06%
Mar 31, 20024.86M1.85M61.20%
Mar 31, 20013.02M1.02M50.71%
Mar 31, 20002.00M433.69K27.65%
Mar 31, 19991.57M252.51K19.19%
Mar 31, 19981.32M-82.27K-5.88%
Mar 31, 19971.40M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings